Zealand Pharma A/S (ZLDPF)
OTCMKTS · Delayed Price · Currency is USD
61.06
+2.66 (4.55%)
Jul 24, 2025, 11:24 AM EDT
Zealand Pharma Employees
Zealand Pharma had 335 employees as of December 31, 2024. The number of employees increased by 82 or 32.41% compared to the previous year.
Employees
335
Change (1Y)
82
Growth (1Y)
32.41%
Revenue / Employee
$20,960
Profits / Employee
-$446,158
Market Cap
4.18B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 335 | 82 | 32.41% |
Dec 31, 2023 | 253 | 57 | 29.08% |
Dec 31, 2022 | 196 | -159 | -44.79% |
Dec 31, 2021 | 355 | 26 | 7.90% |
Dec 31, 2020 | 329 | 150 | 83.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Zealand Pharma News
- 7 days ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 5 weeks ago - Zealand Pharma Obesity Therapy Shows Positive Trial Results - Market Watch
- 5 weeks ago - Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide - GlobeNewsWire
- 7 weeks ago - Zealand Pharma increases its share capital as a result of the exercise of employee warrants - GlobeNewsWire
- 7 weeks ago - Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome - GlobeNewsWire
- 2 months ago - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons - GlobeNewsWire
- 2 months ago - European stocks edge higher after Trump delays 50% tariffs on EU - CNBC
- 2 months ago - European stocks recover after Trump delays EU tariffs in hopes of deal - Reuters